Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion

BackgroundTransfusion of COVID-19 convalescent plasma (CCP) containing high titers of anti-SARS-CoV-2 antibodies serves as therapy for COVID-19 patients. Transfusions early during disease course was found to be beneficial. Lessons from the SARS-CoV-2 pandemic could inform early responses to future p...

Full description

Bibliographic Details
Main Authors: Oliver F. Wirz, Katharina Röltgen, Bryan A. Stevens, Suchitra Pandey, Malaya K. Sahoo, Lorna Tolentino, Michelle Verghese, Khoa Nguyen, Molly Hunter, Theo Thomas Snow, Abhay Raj Singh, Catherine A. Blish, Jennifer R. Cochran, James L. Zehnder, Kari C. Nadeau, Benjamin A. Pinsky, Tho D. Pham, Scott D. Boyd
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
COVID-19
convalescent plasma for COVID-19 therapy
humoral immune response
antiviral antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.739037/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.739037/full

Similar Items